Upsher Smith News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ahead of Bio International, we had an conversation with Bora Pharmaceuticals to get a glimpse of what they have in store for the event.

Despite a highlight story on 60 Minutes last month, fluvoxamine, a drug typically used to treat obsessive-compulsive disorder (OCD), is still just a brief mention in the "cytokine inhibitors" section in the For now, it makes sense. Fluvoxamine, a serotonin reuptake inhibitor (SSRI), has shown promise in two smaller studies, but larger trials have not been published yet. Even if the drug becomes a more mainstream treatment for COVID-19, one expert says any demand surge is not expected to result in shortages. COVID-19 treatment potential As 60 Minutes tells it, the first COVID-19–related f...

email article Since the early days of the pandemic, researchers have been trying to use old drugs for new tricks, raising hopes and spurring controversy. Some of these, like hydroxychloroquine, turned out to be flops, while others are still debated. Recently, another old drug called fluvoxamine has come onto the scene. MedPage Today explores how the old antidepressant has made its way to the COVID spotlight. Fluvoxamine and the COVID Early Treatment Fund Fluvoxamine is the poster child of the COVID-19 Early Treatment Fund (CETF). According to its founder, serial tech entrepreneur Steve...